Enderle Daniel, Spiel Alexandra, Coticchia Christine M, Berghoff Emily, Mueller Romy, Schlumpberger Martin, Sprenger-Haussels Markus, Shaffer Jonathan M, Lader Eric, Skog Johan, Noerholm Mikkel
Exosome Diagnostics GmbH, Am Klopferspitz 19a, 82152 Martinsried, Germany.
Exosome Diagnostics Inc., 840 Memorial Drive, Suite 3, Cambridge MA 02139, United States of America.
PLoS One. 2015 Aug 28;10(8):e0136133. doi: 10.1371/journal.pone.0136133. eCollection 2015.
Exosomes and other extracellular vesicles (commonly referred to as EVs) have generated a lot of attention for their potential applications in both diagnostics and therapeutics. The contents of these vesicles are the subject of intense research, and the relatively recent discovery of RNA inside EVs has raised interest in the biological function of these RNAs as well as their potential as biomarkers for cancer and other diseases. Traditional ultracentrifugation-based protocols to isolate EVs are labor-intensive and subject to significant variability. Various attempts to develop methods with robust, reproducible performance have not yet been completely successful. Here, we report the development and characterization of a spin column-based method for the isolation of total RNA from EVs in serum and plasma. This method isolates highly pure RNA of equal or higher quantity compared to ultracentrifugation, with high specificity for vesicular over non-vesicular RNA. The spin columns have a capacity to handle up to 4 mL sample volume, enabling detection of low-abundance transcripts in serum and plasma. We conclude that the method is an improvement over traditional methods in providing a faster, more standardized way to achieve reliable high quality RNA preparations from EVs in biofluids such as serum and plasma. The first kit utilizing this new method has recently been made available by Qiagen as "exoRNeasy Serum/Plasma Maxi Kit".
外泌体和其他细胞外囊泡(通常称为EVs)因其在诊断和治疗方面的潜在应用而备受关注。这些囊泡的内容物是深入研究的对象,并且最近在EVs内部发现RNA引发了人们对这些RNA的生物学功能及其作为癌症和其他疾病生物标志物潜力的兴趣。传统的基于超速离心的EVs分离方案劳动强度大且存在显著的变异性。开发具有稳健、可重复性能方法的各种尝试尚未完全成功。在此,我们报告了一种基于离心柱从血清和血浆中的EVs分离总RNA的方法的开发与特性。与超速离心相比,该方法能分离出等量或更多的高纯度RNA,对囊泡RNA而非非囊泡RNA具有高度特异性。离心柱能够处理高达4 mL的样品体积,从而能够检测血清和血浆中的低丰度转录本。我们得出结论,该方法在提供一种更快、更标准化的方式以从血清和血浆等生物流体中的EVs获得可靠的高质量RNA制剂方面,是对传统方法的一种改进。利用这种新方法的首个试剂盒最近已由Qiagen作为“exoRNeasy Serum/Plasma Maxi Kit”推出。